Genmab, Capital Increase in Genmab as a Result of Execution of Private Placement to GlaxoSmithKline

| Source: Genmab A/S Genmab A/S 

Genmab increases its share capital by 4,471,202 shares as a result of execution of private placement to GlaxoSmithKline.

Attachments

102783.pdf